336 related articles for article (PubMed ID: 30958800)
1. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.
Wakimoto H
J Clin Invest; 2019 Apr; 129(5):1833-1835. PubMed ID: 30958802
[TBL] [Abstract][Full Text] [Related]
3. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
[TBL] [Abstract][Full Text] [Related]
5. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
[TBL] [Abstract][Full Text] [Related]
6. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.
Zhang Q; Chen Z; Tang Q; Wang Z; Lu J; You Y; Wang H
Cell Death Dis; 2022 Aug; 13(8):712. PubMed ID: 35974001
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
8. ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
Li G; Li Y; Liu X; Wang Z; Zhang C; Wu F; Jiang H; Zhang W; Bao Z; Wang Y; Cai J; Zhao L; Kahlert UD; Jiang T; Zhang W
Cell Death Dis; 2018 Dec; 9(12):1190. PubMed ID: 30538217
[TBL] [Abstract][Full Text] [Related]
9. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
[TBL] [Abstract][Full Text] [Related]
10. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V
Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812
[TBL] [Abstract][Full Text] [Related]
11. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
Zhang W; Liu Y; Hu H; Huang H; Bao Z; Yang P; Wang Y; You G; Yan W; Jiang T; Wang J; Zhang W
PLoS One; 2015; 10(11):e0142856. PubMed ID: 26575197
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
[TBL] [Abstract][Full Text] [Related]
13. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
14. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
[TBL] [Abstract][Full Text] [Related]
15. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
Wu W; Schecker J; Würstle S; Schneider F; Schönfelder M; Schlegel J
Cancer Lett; 2018 Mar; 417():112-123. PubMed ID: 29306018
[TBL] [Abstract][Full Text] [Related]
17. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.
Gelardi ELM; Caprioglio D; Colombo G; Del Grosso E; Mazzoletti D; Mattoteia D; Salamone S; Ferraris DM; Aronica E; Nato G; Buffo A; Rizzi M; Magrassi L; Minassi A; Garavaglia S
Commun Biol; 2022 Sep; 5(1):895. PubMed ID: 36050388
[TBL] [Abstract][Full Text] [Related]
19. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
